Other
Total
Merck & Co. Total increased by 371.3% to $476.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.0%, from $690.00M to $476.00M. Over 5 years (FY 2020 to FY 2025), Total shows an upward trend with a 2.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 4, 2026
How to read this metric
Changes reflect shifts in the cost basis of the investment portfolio due to purchasing or selling activity.
Detailed definition
The amortized cost basis of debt securities classified as available-for-sale, excluding primary categories. This represe...
Peer comparison
Commonly reported by insurers with large fixed-income portfolios.
Metric ID:
other_available_for_sale_debt_securities_amortized_cost_basisHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $88.00M | $89.00M | $86.00M | $454.00M | $412.00M | $76.00M | $569.00M | $760.00M | $821.00M | $247.00M | $337.00M | $117.00M | $127.00M | $81.00M | $536.00M | $690.00M | $707.00M | $145.00M | $101.00M | $476.00M |
| QoQ Change | — | +1.1% | -3.4% | +427.9% | -9.3% | -81.6% | +648.7% | +33.6% | +8.0% | -69.9% | +36.4% | -65.3% | +8.5% | -36.2% | +561.7% | +28.7% | +2.5% | -79.5% | -30.3% | +371.3% |
| YoY Change | — | — | — | — | +368.2% | -14.6% | +561.6% | +67.4% | +99.3% | +225.0% | -40.8% | -84.6% | -84.5% | -67.2% | +59.1% | +489.7% | +456.7% | +79.0% | -81.2% | -31.0% |
Range$76.00M – $821.00M
CAGR+42.7%
Avg YoY Growth+125.1%
Median YoY Growth+63.2%
Total at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s total?
- Merck & Co. (MRK) reported total of $476.00M in Q1 2026.
- How has Merck & Co.'s total changed year-over-year?
- Merck & Co.'s total decreased by 31.0% year-over-year, from $690.00M to $476.00M.
- What is the long-term trend for Merck & Co.'s total?
- Over 5 years (2020 to 2025), Merck & Co.'s total has grown at a 2.6% compound annual growth rate (CAGR), from $89.00M to $101.00M.
- What does total mean?
- The original cost of debt investments held for sale, adjusted for accounting amortization.